Mania in children and adolescents: Recognition and treatment

Psychiatric Annals

Volumn 26, Issue 7 SUPPL., 1996, Pages

  Bowden, Charles L ^a   Rhodes, Linda J ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21344448999     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19960702-04     Document Type: Article

References (42)

1. Winokur G, Clayton P, Reich T. Manic-Depressive Illness. St. Louis, Mo: CV Mosby; 1969.
2. Loranger AW, Levine PM. Age at onset of bipolar affective illness. Arch Gen Psychiatry. 1978;35:1345-1348.
3. Joyce PR. Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia. Psychol Med. 1984; 14:145-149.
4. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry. 1995;34:454-463.
5. Egeland JA, Hosteller AM. Amish study I: affective disorders among the Amish, 1976-1980. Am J Psychiatry. 1983;140:56-61.
6. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RMA. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31:281-294.
7. Weller RA, Weller EB, Tucker SG, et al. Mania in prepubertal children: has it been underdiagnosed. J Affect Disord. 1986;11:151-154.
8. Carlson GA, Fennig S, Bromet EJ. The confusion between bipolar disorder and schizophrenia in youth: where does it stand in the 1990's. J Am Acad Child Adolesc Psychiatry. 1994;33:453-460.
9. Todd RD, Reich W, Reich T. Prevalence of affective disorder in the child and adolescent offspring of a single kindred: a pilot study. J Am Acad Child Adolesc Psychiatry. 1994;33:198-207.
10. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-Induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995;152:1130-1138.
11. Popper CW. Balancing knowledge and judgment: a clinician looks at new developments in child and adolescent psychopharmacology. Pediatric Psychopharmacology II. 1995;4:483-510.
12. Geller B, Fox LW, Clark KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry. 1994;33:461-468.
13. Strober M, Carlson G. Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry. 1982;39:549-555.
14. Rao U, Ryan ND, Birmaher B, et al. Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry. 1995;34:566-578.
15. Wozniak J, Biederman J, Kiely K, et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry. 1995;34:867-876.
16. McClellan JM, Werry JS, Ham M. A follow-up study of early onset psychosis: comparison between outcome diagnoses of schizophrenia, mood disorders, and personality disorders. J Autism Dev Disord. 1993;23:243-262.
17. Weller EB, Weller RA, Fristad MA. Bipolar disorder in children: misdiagnosis, underdiagnosis, and future directions. J Am Acad Child Adolesc Psychiatry. 1995;34:709-714.
18. West SA, McElroy SL, Strakowski SM, Keck PE, McConville BJ. Attention deficit hyperactivity disorder in adolescent mania. Am J Psychiatry. 1995;152:271-273.
19. Biederman J, Wozniak J, Kiely K, et al. CBCL clinical scales discriminate prepubertal children with structured interview-derived diagnosis of mania from those with ADHD. J Am Acad Child Adolesc Psychiatry. 1995;34: 464-471.
20. Achenbach TM. "Comorbidity" in child and adolescent psychiatry: categorical and quantitative perspectives. J Child Adolesc Psychopharmacol. 1991;1:271-278.
21. Trimble MR, Thompson PJ. Sodium valproate and cognitive function. Epilepsia. 1984;25:560-564.
22. Bowden CL. The clinical efficacy of divalproex in the treatment of affective disorders. Rev Contemporary Pharmacotherapy. 1995;6:557-571.
23. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA. 1994;271:918-924.
24. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry. 1991;48:62-68.
25. Papatheodorou G, Kutcher SP. Divalproex sodium treatment in late adolescent and young adult acute mania. Psychopharmacol Bull. 1993;29:213-219.
26. Bowden CL, Janicak PG, Orsulak P, et al. Relationship of serum valproate concentration to response in mania. Am J Psychiatry. 1996. In press.
27. Delgado MR. Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol. 1994;9:311-314.
28. Lambert PA, Venaud G. Comparative study of valpromide versus lithium in the treatment of affective disorders. Nervure Journal de Psychiatrie. 1992;5:57-65.
29. Lambert PA, Venaud G. Comparative study of valpromide versus lithium as prophylactic treatment in affective disorders. Nervure Journal de Psychiatrie. 1995;1-9.
30. Strober M, Morrell W, Lampert C, Burroughs. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry. 1990;147:457-461.
31. Kafantaris V. Treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34:732-741.
32. Strober M, Morrell W, Burrough G, et al. A study of bipolar I disorder in adolescence: early onset of symptoms linked to increased family loading and lithium resistance. J Affect Disord. 1988;15:255-268.
33. Alessi N, Naylor MW, Ghaziuddi M, Zubieta JK. Update on lithium carbonate therapy in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1994;33:291-304.
34. Campbell M, Silva RR, Kafantaris V, et al. Predictors of side effects associated with lithium administration in children. Psychopharmacol Bull. 1991;27:373-380.
35. Silva RR, Campbell M, Golden RR, Small AM, Pataki CS, Rosenberg CR. Side effects associated with lithium and placebo administration in aggressive children. Psychopharmacol Bull. 1992;28:319-326.
36. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A re-evaluation of risk of in utero exposure to lithium. JAMA. 1994;271:146-150.
37. Bowden CL, Houston JP, Shulman RS, Clothier JM. Clinical utility of salivary lithium concentration. International Pharmacopsychiatry. 1982;17:104-113.
38. Vahip S, Ozkan B, Ayan A, Korokoglu S, Tuglular I. Elevation of plasma lithium at the end of mania and some biochemical correlates. Second International Conference on New Directions in Affective Disorders, Jerusalem. 1995:31. Abstract.
39. Bowden CL. Carbamazepine in bipolar disorder. In: Goodnick PJ, ed. Predictors of Treatment Response in Mood Disorders. Washington, DC: American Psychiatric Press, Inc; 1996:119-132.
40. Janicak PG, Davis JM, Preskorn SH, Ayd TJ. Principles and Practice of Psychopharmacotherapy. Baltimore, Md: Williams & Wilkins; 1993.
41. Carpenter RO, Vining EPG. Antiepileptics (anticonvulsants), In: Werry JS, Aman MG, eds. Practitioner's Guide to Psychoactive Drugs for Children and Adolescents. New York, NY: Plenum Medical; 1993.
42. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press, Inc., 1990.